Presentation TCT 2017 Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow? Presenter: Bernardo Cortese October 30, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 DES/BRS/DCB Up Next Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Fernando Alfonso October 30, 2017 More slides + Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Ron Waksman October 30, 2017 Presentation TCT 2017 Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited Presenter: Paul A. Sobotka October 30, 2017 We Recommend
Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Fernando Alfonso October 30, 2017
Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Ron Waksman October 30, 2017
Presentation TCT 2017 Targets for Device-Based Hypertension Treatments Beyond the Kidneys: Physiology Revisited Presenter: Paul A. Sobotka October 30, 2017